A detailed history of Royal Bank Of Canada transactions in Gh Research PLC stock. As of the latest transaction made, Royal Bank Of Canada holds 1,000 shares of GHRS stock, worth $7,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,097 8.84%
Holding current value
$7,090
Previous $12,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.69 - $12.49 $648 - $1,211
-97 Reduced 8.84%
1,000 $6,000
Q2 2024

Aug 14, 2024

BUY
$10.5 - $14.81 $1,018 - $1,436
97 Added 9.7%
1,097 $12,000
Q1 2024

Nov 05, 2024

SELL
$5.34 - $11.09 $517 - $1,075
-97 Reduced 8.84%
1,000 $10,000
Q3 2022

Nov 14, 2022

SELL
$10.15 - $16.15 $45,329 - $72,125
-4,466 Reduced 81.71%
1,000 $12,000
Q2 2022

Aug 15, 2022

BUY
$8.99 - $19.87 $49,139 - $108,609
5,466 New
5,466 $55,000

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $369M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.